These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 36179654)

  • 1. Treatment and outcomes of non-aneurysmal perimesencephalic subarachnoid haemorrhage: A 5 year retrospective study in a tertiary care centre.
    Haugh JP; Turkalp Z; Sivam H; Gatt S; Kaliaperumal C
    Clin Neurol Neurosurg; 2022 Nov; 222():107448. PubMed ID: 36179654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A quantitative model to differentiate nonaneurysmal perimesencephalic subarachnoid hemorrhage from aneurysmal etiology.
    Mandel D; Moody S; Pan K; Subramaniam T; Thompson BB; Wendell LC; Reznik ME; Furie KL; Mahta A
    J Neurosurg; 2023 Jan; 138(1):165-172. PubMed ID: 35523263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical and serial angiographic study in patients with subarachnoid hemorrhage of unknown etiology with special reference to the clot distribution of perimesencephalic nonaneurysmal subarachnoid hemorrhage].
    Nakagawa K; Aoyagi M; Maehara T; Tamaki M; Inaji M; Kawano Y; Mukawa M; Yamamoto S; Ohno K
    No Shinkei Geka; 2009 Aug; 37(8):771-8. PubMed ID: 19663335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffuse Angiogram-Negative Subarachnoid Hemorrhage is Associated with an Intermediate Clinical Course.
    Akbik F; Pimentel-Farias C; Press DA; Foster NE; Luu K; Williams MG; Andea SG; Kyei RK; Wetsel GM; Grossberg JA; Howard BM; Tong F; Cawley CM; Samuels OB; Sadan O
    Neurocrit Care; 2022 Jun; 36(3):1002-1010. PubMed ID: 34932193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term global and focal cerebral atrophy in perimesencephalic subarachnoid hemorrhage-a case-control study.
    Gama Lobo G; Fragata I
    Neuroradiology; 2022 Apr; 64(4):669-674. PubMed ID: 34495354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline characteristics and outcome for aneurysmal versus non-aneurysmal subarachnoid hemorrhage: a prospective cohort study.
    Conzen C; Weiss M; Albanna W; Seyfried K; Schmidt TP; Nikoubashman O; Stoppe C; Clusmann H; Schubert GA
    Neurosurg Rev; 2022 Apr; 45(2):1413-1420. PubMed ID: 34604940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The negative predictive value of CT angiography in the setting of perimesencephalic subarachnoid hemorrhage.
    Mortimer AM; Appelman AP; Renowden SA
    J Neurointerv Surg; 2016 Jul; 8(7):728-31. PubMed ID: 26044985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of Arterial Hypotension in Patients Receiving Peroral or Continuous Intra-arterial Nimodipine After Aneurysmal or Perimesencephalic Subarachnoid Hemorrhage.
    Kieninger M; Gruber M; Knott I; Dettmer K; Oefner PJ; Bele S; Wendl C; Tuemmler S; Graf B; Eissnert C
    Neurocrit Care; 2019 Aug; 31(1):32-39. PubMed ID: 30725331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in the basilar artery bifurcation angle among patients who present with a ruptured aneurysm at the top of the basilar artery and patients with perimesencephalic subarachnoid hemorrhage: a retrospective cross-sectional study.
    Jagadeesan BD; Kadkhodayan Y; Delgado Almandoz JE; Wallace A; Cross DT; Derdeyn CP; Zipfel GJ; Dacey RG; Moran CJ
    Neurosurgery; 2013 Jul; 73(1):2-7. PubMed ID: 23615096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perimesencephalic subarachnoid hemorrhage: incidence, risk factors, and outcome.
    Flaherty ML; Haverbusch M; Kissela B; Kleindorfer D; Schneider A; Sekar P; Moomaw CJ; Sauerbeck L; Broderick JP; Woo D
    J Stroke Cerebrovasc Dis; 2005; 14(6):267-71. PubMed ID: 16518463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An analysis of 88 patients with diffuse and "benign" perimesencephalic subarachnoid hemorrhage.
    Patel NB; Patel AD; Wilkinson J; Gianaris NG; Payner TD; Leipzig TJ; Ansari S; Cohen-Gadol AA
    J Neurol Surg A Cent Eur Neurosurg; 2014 Jul; 75(4):299-304. PubMed ID: 24554610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of cerebral-cardiac syndrome caused by nonaneurysmal or aneurysmal subarachnoid hemorrhage.
    Huang WJ; Chen WW; Zhang X
    Eur Rev Med Pharmacol Sci; 2014; 18(24):3737-42. PubMed ID: 25555860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic interleukin-6 concentrations in patients with perimesencephalic non-aneurysmal subarachnoid hemorrhage.
    Muroi C; Bellut D; Coluccia D; Mink S; Fujioka M; Keller E
    J Clin Neurosci; 2011 Dec; 18(12):1626-9. PubMed ID: 22019436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intra-arterial nimodipine for severe cerebral vasospasm after aneurysmal subarachnoid haemorrhage - neurological and radiological outcome.
    Samuelsson J; Sunila M; Rentzos A; Nilsson D
    Neuroradiol J; 2022 Apr; 35(2):213-219. PubMed ID: 34350797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiogram negative subarachnoid haemorrhage: outcomes and the role of repeat angiography.
    Khan AA; Smith JD; Kirkman MA; Robertson FJ; Wong K; Dott C; Grieve JP; Watkins LD; Kitchen ND
    Clin Neurol Neurosurg; 2013 Aug; 115(8):1470-5. PubMed ID: 23485251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcome and quality of life after nonaneurysmal subarachnoid hemorrhage.
    Beseoglu K; Pannes S; Steiger HJ; Hänggi D
    Acta Neurochir (Wien); 2010 Mar; 152(3):409-16. PubMed ID: 19784546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.
    Ehlert A; Schmidt C; Wölfer J; Manthei G; Jacobs AH; Brüning R; Heindel W; Ringelstein EB; Stummer W; Pluta RM; Hesselmann V
    J Neurosurg; 2016 Jan; 124(1):51-8. PubMed ID: 26162034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the calcium-antagonist nimodipine for the prevention of vasospasm after aneurysmal subarachnoid haemorrhage. A prospective transcranial Doppler ultrasound study.
    Seiler RW; Grolimund P; Zurbruegg HR
    Acta Neurochir (Wien); 1987; 85(1-2):7-16. PubMed ID: 2955675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of 14 Versus 21 Days of Nimodipine Therapy on Neurological Outcomes in Aneurysmal Subarachnoid Hemorrhage Patients.
    Cho S; Bales J; Tran TK; Korab G; Khandelwal N; Joffe AM
    Ann Pharmacother; 2016 Sep; 50(9):718-24. PubMed ID: 27273676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial.
    Pickard JD; Murray GD; Illingworth R; Shaw MD; Teasdale GM; Foy PM; Humphrey PR; Lang DA; Nelson R; Richards P
    BMJ; 1989 Mar; 298(6674):636-42. PubMed ID: 2496789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.